학술논문
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Document Type
Artikel
Author
De Laere, B; Oeyen, S; Mayrhofer, M; Whitington, T; van Dam, PJ; Van Oyen, P; Ghysel, C; Ampe, J; Ost, P; Demey, W; Hoekx, L; Schrijvers, D; Brouwers, B; Lybaert, W; Everaert, EG; De Maeseneer, D; Strijbos, M; Bols, A; Fransis, K; Beije, N; de Kruijff, IE; van Dam, V; Brouwer, A; Goossens, D; Heyrman, L; Van den Eynden, GG; Rutten, A; Del Favero, J; Rantalainen, M; Rajan, P; Sleijfer, S; Ullen, A; Yachnin, J; Gronberg, H; Van Laere, SJ; Lindberg, J; Dirix, LY
Source
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(6):1766-1773
Subject
Language
English
English
English
ISSN
1557-3265